Compare ACCO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCO | LFCR |
|---|---|---|
| Founded | 1893 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.1M | 296.0M |
| IPO Year | N/A | N/A |
| Metric | ACCO | LFCR |
|---|---|---|
| Price | $3.79 | $7.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 793.0K | 176.0K |
| Earning Date | 02-19-2026 | 01-02-2026 |
| Dividend Yield | ★ 7.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $1,544,000,000.00 | $128,867,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | $0.83 | $11.51 |
| P/E Ratio | $8.70 | ★ N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $3.20 | $4.76 |
| 52 Week High | $5.68 | $8.85 |
| Indicator | ACCO | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 58.52 | 50.12 |
| Support Level | $3.63 | $7.66 |
| Resistance Level | $3.78 | $8.36 |
| Average True Range (ATR) | 0.08 | 0.43 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 62.96 | 35.03 |
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.